Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective-Reference-Cited by-全球学者库

Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective

Published:2023-03-01 Issue:6 Volume:66 Page:3664-3702
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Pozzi Cecilia¹^ORCID,Vanet Anne²,Francesconi Valeria³,Tagliazucchi Lorenzo⁴⁵^ORCID,Tassone Giusy¹^ORCID,Venturelli Alberto⁴,Spyrakis Francesca⁶^ORCID,Mazzorana Marco⁷,Costi Maria P.⁴^ORCID,Tonelli Michele³^ORCID

Affiliation:

1. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, via Aldo Moro 2, 53100 Siena, Italy

2. Université Paris Cité, CNRS, Institut Jacques Monod, F-75013 Paris, France

3. Department of Pharmacy, University of Genoa, viale Benedetto XV n.3, 16132 Genoa, Italy

4. Department of Life Science, University of Modena and Reggio Emilia, via Campi 103, 41125 Modena, Italy

5. Doctorate School in Clinical and Experimental Medicine (CEM), University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy

6. Department of Drug Science and Technology, University of Turin, Via Giuria 9, 10125 Turin, Italy

7. Diamond Light Source, Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01229

Reference262 articles.

1. Coronaviruses — drug discovery and therapeutic options

2. Treatment for COVID-19: An overview

3. COVID-19 Disease Map. COVID-19 research resources. https://covid.pages.uni.lu// (accessed 2022-05-13).

4. Proteases and protease inhibitors in infectious diseases

5. Recent progress in the discovery of inhibitors targeting coronavirus proteases

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors;European Journal of Medicinal Chemistry;2024-01

2. Favipiravir vs. Deferiprone: Tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2;Current Research in Biotechnology;2024

3. Exploring binding mechanisms of omicron spike protein with dolutegravir and etravirine by molecular dynamics simulation, principal component analysis, and free binding energy calculations;Journal of Biomolecular Structure and Dynamics;2023-12-12

4. Design, synthesis, and structure-activity relationships of a novel class of quinazoline derivatives as coronavirus inhibitors;European Journal of Medicinal Chemistry;2023-12

5. Identification of potential antiviral lead inhibitors against SARS-CoV-2 main protease: Structure-guided virtual screening, docking, ADME, and MD Simulation based approach;Artificial Intelligence Chemistry;2023-12